ASCO 2024: Bispecific Highlights Infographic
Covered in this Infographic:
- Analysis of the 150 bispecific-related abstracts presented at ASCO 2024.
- Insights into top disease indications, targets, and target combinations.
- Current trends in the bispecific landscape.
To learn more about the infographic and how Beacon Bispecific can enhance your data needs and provide fast insights, please book a research session below or contact us directly on beacon@hansonwade.com.
You May Also Be Interested In…
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
